Why Others Lose More Weight on the Same Semaglutide Dose Than You Do

Because response to these medications varies enormously between people, and the numbers you are comparing yourself against are mostly averages or the loudest results rather than a typical outcome. Nothing about losing less than someone else at the same dose indicates that something is wrong with you. It indicates that you are two different people, which the trial data expects.

It is worth understanding how wide that spread actually is, because the comparison you are making is almost certainly against a distorted sample.

The trials show a range, not a number

In the main trial of once-weekly semaglutide for weight management, the headline figure was a mean. Underneath that mean was a wide distribution: some participants lost a great deal, a large group landed in the middle, and a meaningful minority lost relatively little.

The number that gets repeated is the average of all of them. Half of the people in any trial, by definition, did worse than the average. Those people were not doing it wrong. They were the other half of the number everyone quotes.

The same is true of every medication in this class. Individual response varies for reasons that are not well understood and are largely not within anyone’s control.

What genuinely differs between people

Starting point. Someone with more weight to lose usually loses more in absolute terms, and often faster early. Comparing pounds against someone with a different starting weight compares two different situations.

Biology. Response varies for reasons that are not fully mapped. Some of it is likely genetic, some hormonal, some related to other conditions.

Other medications. Several common ones, including some antidepressants, antipsychotics, steroids, and certain diabetes medications, make weight loss harder. This is a real effect and it is nobody’s fault.

Where you are in treatment. Someone three months in is on the steep part of the curve. Someone ten months in is not. Comparing them compares two phases.

What is actually being compared. Absolute pounds, percentage of body weight, and inches are different measures that can rank people differently.

Who you are comparing against

The sample is skewed, and worth naming.

People who lose a lot post about it. People who lose modestly usually say nothing. Online, in support groups, and in conversation, the visible results are systematically the better ones. You are comparing your full experience against other people’s highlights.

There is also survivorship in it. People who stopped, or for whom it did not work, are not in the group still talking about it.

Consider this scenario: a patient six months in has lost a steady, unglamorous amount and feels like a failure because two people at work have lost noticeably more. One of them started forty pounds heavier and is three months behind, so they are in the fast early phase. The other has not mentioned that they completed dose escalation while this patient stopped partway. Neither comparison was ever informative, and one of them contained the actual finding.

The comparison worth making

Against yourself, on measures that reflect what you are trying to achieve.

Your own trend. Where were you three months ago, six months ago?

Percentage rather than pounds. Loss of five to ten percent of body weight is clinically meaningful, and it lands very differently in pounds depending on where you started.

Measurements and how clothes fit. Composition can change while the scale is slower.

Health markers. Blood pressure, blood sugar, sleep, joint pain, mobility. These improve on a different schedule from the scale and are often the point.

How you feel. Energy, food noise, and whether eating has stopped occupying your attention.

Our guide to tracking your progress covers how to set this up so you have your own baseline to measure against.

When slower is worth investigating

Comparison is unhelpful. That does not mean every rate is fine. Raise it with your provider if:

• You have lost very little after several months at a maintenance dose
• You never completed escalation
• Your trend has been flat for eight weeks or more
• Appetite is not meaningfully suppressed at your current dose
• You take a medication known to work against weight loss

Those are reasons to talk about your treatment. None of them is a reason to talk about yourself.

What not to do

Do not eat less to catch up. Comparison-driven restriction is how a workable plan becomes an unhealthy one, and it brings the under-eating pattern: persistent fatigue, feeling cold, hair shedding, dizziness on standing, losing strength.

Do not ask for a dose increase because of someone else’s results. Ask because of your own trend.

Do not switch products chasing a number. Different medications in this class do have different average results, and our comparison of tirzepatide and semaglutide side effects covers what else differs, but switching restarts titration and should be a clinical decision rather than a competitive one.

Do not conclude you are a non-responder from a comparison. That is a specific clinical picture, not a relative one.

If the comparison itself is the problem

If you are checking other people’s results often, if your mood tracks how you are doing against them, or if the comparison has made you feel worse than the weight ever did, that is worth attention in its own right. Muting the accounts is a reasonable start. Saying it to your provider is better.

The short version

Trial averages hide a wide spread, and half of every trial did worse than the number you have heard. The people you can see are the ones who did well. Compare yourself against your own trend, in percentage rather than pounds, and bring your rate to your provider only if it is slow against your own history rather than against someone else’s.

If you want a provider who will assess your results against your own baseline, TrimRx includes ongoing provider access alongside treatment, and our guide on getting the most out of your GLP-1 treatment covers what actually moves your own numbers.

This information is for educational purposes and is not medical advice. Consult with a healthcare provider before starting any medication. Individual results may vary.